GlaxoSmithKline Inc.
GlaxoSmithKline Inc. (GSK), a leading global healthcare company, is headquartered in California and operates extensively across North America, Europe, and Asia. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has established itself as a key player in the pharmaceutical and biotechnology sectors, focusing on research and development in vaccines, pharmaceuticals, and consumer healthcare products. GSK's core offerings include innovative medicines for respiratory, HIV, and oncology treatments, as well as a robust portfolio of vaccines and consumer health products. The company is renowned for its commitment to scientific excellence and patient-centric solutions, which have positioned it among the top pharmaceutical firms worldwide. With a strong emphasis on sustainability and access to healthcare, GSK continues to achieve significant milestones in improving global health outcomes.
DitchCarbon Score
How does GlaxoSmithKline Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline Inc.'s score of 59 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline Inc.'s reported carbon emissions
GlaxoSmithKline Inc., headquartered in California, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is challenging to assess their current emissions status or commitments to climate action. However, the company is expected to align with industry standards and best practices in addressing climate change. As part of the pharmaceutical sector, GSK is likely to engage in initiatives aimed at reducing its carbon footprint and enhancing sustainability. Further details on their climate commitments or specific reduction initiatives are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
